Dirk van den Brand

Peptide-mediated delivery of therapeutic mRNA in ovarian cancer

Dirk van den Brand, Mark A.J. Gorris, Alexander H. van Asbeck et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 88 citations

Pharmacy, Oncology, Pharmaceutics +13

Umbilical cord blood CD34⁺progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg^nullmice

Janneke S. Hoogstad‐van Evert, Jeannette Cany, Dirk van den Brand et al. · OncoImmunology · 2017 · 68 citations · Full text

Life Sciences, Immunology, Oncology +17

The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates

Sanne A. M. van Lith, Dirk van den Brand, Rike Wallbrecher et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 43 citations · Full text

Medicine, Oncology, Pharmaceutics +17

Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides

Dirk van den Brand, Cornelia Veelken, Leon F.A.G. Massuger et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2018 · 34 citations

Pharmacy, Cancer Biology, Oncology +17

A Conjugate of an Anti‐Epidermal Growth Factor Receptor (EGFR) VHH and a Cell‐Penetrating Peptide Drives Receptor Internalization and Blocks EGFR Activation

Sanne A. M. van Lith, Dirk van den Brand, Rike Wallbrecher et al. · ChemBioChem · 2017 · 28 citations

Pharmacy, Oncology, Pharmacology +17